use of a combination of at least torasemide and baclofen, or sustained release salts, prodrugs, derivatives, or formulations thereof, use of at least torasemide and baclofen, or sustained release salts, prodrugs, derivatives, or formulations and use of a composition comprising at least torasemide and baclofen, or salts, prodrugs, derivatives, or sustained release formulations thereof

摘要

abstract use of a combination of at least torasemide and baclofen, or salts, prodrugs, derivatives, or sustained release formulations thereof, use of at least torasemide and baclofen, or salts, prodrugs, derivatives, or release formulations and use of a composition comprising at least torasemide and baclofen, or salts, prodrugs, derivatives, or sustained release formulations thereof The present invention relates to compositions and methods for the treatment of excitotoxicity-related neurological disorders of glutamate and amyloid toxicity? more specifically, the present invention relates to novel combinatorial therapies of multiple sclerosis, alzheimer's disease, disorders related to alzheimer's disease, amyotrophic lateral sclerosis, parkinson's disease, huntington's disease, neuropathic pain, alcoholic neuropathy, alcoholism or abstinence from alcohol, or spinal cord injury. 1/1